openPR Logo
Press release

Gastric Cancer Therapeutics Market Growth, Revenue Analysis And Competition by Manufacturers 2018 To 2026

01-15-2019 01:01 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Gastric Cancer Therapeutics

Gastric Cancer Therapeutics

Gastric cancer, also known as stomach cancer, is a type of cancer that develops within the inside layer of the stomach. Symptoms may include upper abdominal pain, yellowing of the skin, heartburn, sudden weight loss, blood in the stool, loss of appetite, and nausea, among others. This type of cancer may multiply to unaffected parts of the body mainly to the lungs, liver, the lining of the abdomen, lymph nodes, and bones. The key cause of gastric cancer is contagion by Helicobacter pylori. This accounts for around 60% of the gastric cancer cases. Some types of H. pylori comprise larger risks than the others. Some of the other causes include smoking and eating pickled vegetables. Around 1 in 10 cases of gastric cancer are inherited and 1% to 3% of the cases are due to hereditary syndromes such as hereditary gastric cancer. Most cases of gastric cancers are gastric carcinomas.

Some of the companies operating in the gastric cancer therapeutics market in the current scenario are Pfizer, Eli Lilly, GlaxoSmithKline plc, Kuhnil Pharmaceutical/Daiichi Sankyo, BMS, Merck KGaA, AstraZeneca, Otsuka Holdings Co. Ltd., Sanofi, and F. Hoffmann-La Roche Ltd. Some of the other companies operating in the market are Ono Pharmaceutical/Bristol-Myers Squibb, Jiangsu HengRui Medicine, Gilead Bioscience, Celgene/Taiho, Boston Biomedical, and Merck.

Request For Sample Copy of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/194

Gastric cancer therapeutics market taxonomy
On the basis of type of treatment, the global market is classified into:
Surgery
Targeted drugs therapy
Chemotherapy
Radiation therapy
Others

On the basis of end user, the global market is classified into:
Hospitals
Clinics
Specialized cancer treatment centers
Ambulatory surgical centers
Others

Increasing prevalence of the disease in the Asia to drive growth of overall gastric cancer therapeutics market

Survival rate for stomach cancer is greatly dependent upon the stage or phase of the disease during diagnosis. The earlier the stage of the disease progression, the higher is the survival rate. In Asia Pacific, the majority of the cases are detected at the later stage of the disease and predominantly among the geriatric population. Growth of the geriatric population in the region is leading to a proportional increase in occurrence of gastric cancer. This factor, along with growing health awareness leading to a rise in demand for early detection would fuel growth of the gastric cancer therapeutics industry over the forecast period.

Presently, the products available in the market constitutes of an extensive variety of treatment alternatives such as angiogenesis inhibitors, new chemotherapies and HER2-targeted therapy. However, demand for therapeutics that can take care of HER2-negative stomach cancer patients is high. Nevertheless, the gastric cancer market is experiencing a gradual change from generic treatment regimen to targeted therapies. This will further enhance the growth of the global gastric cancer therapeutics market.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/194

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: www.coherentwire.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Cancer Therapeutics Market Growth, Revenue Analysis And Competition by Manufacturers 2018 To 2026 here

News-ID: 1499145 • Views: 147

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for Gastric

Gastric Balloon Market: Global Industry Analysis Report 2018
The Gastric Balloon market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Gastric Balloon. This study focuses on the production side and consumption side of Gastric Balloon, presents the global
The Virtual Gastric Band 101
There’s been a lot in the media recently about the Hypnotic Gastric Band or also known as The Virtual Gastric Band. I get asked a lot about it so thought I’d give a Virtual Gastric Band 101 on what it is, but more importantly what it’s not. ​The Virtual Gastric Band - It is a non-surgical technique which uses the power of hypnosis to retrain the person to be satisfied with smaller
Coastal Cosmetics Reshape Gastric Balloon Webinar
Those who are in the dieting industry and related fields, as well as professional medical clinicians, know that weight loss is a hard and complex struggle. In many cases, weight loss is the best way to deal with chronic conditions and prevent major health threats, even those that can be potentially fatal. At the same time, lifestyle changes may not accomplish the results that a patient needs. The Reshape gastric balloon
Global Gastric Ulcers Therapeutic Pipeline Review, H2 2017
"The Report Gastric Ulcers - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H2 2017, provides an overview of the Gastric Ulcers (Gastrointestinal) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of
BRIC Bariatric Surgery Devices Market Segments - Bariatric Stapling Devices, Gas …
"The Report BRIC Bariatric Surgery Devices Market Outlook to 2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" GlobalDatas new report, "BRIC Bariatric Surgery Devices Market Outlook to 2023", provides key market data on the BRIC Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments -
Global Gastric Banding Market Research Report 2017
This report studies Gastric Banding in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Roche Abbott Siemens Alere Nova Request Sample Report: http://www.reportbazzar.com/request-sample/?pid=887564&ptitle=Global+Gastric+Banding+Market+Research+Report+2017&req=Sample Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Gastric Banding in these regions, from 2011 to 2021